haloperidol has been researched along with mdl 100907 in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (22.45) | 18.2507 |
| 2000's | 26 (53.06) | 29.6817 |
| 2010's | 11 (22.45) | 24.3611 |
| 2020's | 1 (2.04) | 2.80 |
| Authors | Studies |
|---|---|
| Giordanetto, F; Leach, AG; Zachariae, U | 1 |
| Fadayel, GM; Schmidt, CJ; Sullivan, CK; Taylor, VL | 1 |
| Kehne, JH; McCloskey, TC; Padich, RA | 1 |
| Bush, LG; Davis, K; Gibb, JW; Hanson, GR; Schmidt, CJ; Taylor, VL | 1 |
| Fischer, TR; Hitchcock, JM; Lister, S; Wettstein, JG | 1 |
| Arvanov, VL; Wang, RY | 1 |
| Hicks, PB; Richter, TJ; Trompler, RA; Wadenberg, ML; Young, KA; Zavodny, RA | 1 |
| Liang, X; Wang, RY | 1 |
| Dai, J; Ichikawa, J; Kuroki, T; Meltzer, HY | 1 |
| Blackburn, TP; Holland, V; Kettle, A; Reavill, C; Riley, G | 1 |
| Carlsson, A; Carlsson, ML; Martin, P; Nilsson, M; Sorensen, SM; Waters, N; Waters, S | 1 |
| Alsayegh, L; Backstrom, JR; Berry, SA; Friedman, L; Roth, BL; Sanders-Bush, E; Willins, DL | 1 |
| Ichikawa, J; Meltzer, HY | 1 |
| Ashby, CR; Hashimoto, K; Minabe, Y; Watanabe, KI | 1 |
| Browning, JL; Hicks, PB; Wadenberg, MG; Young, KA | 1 |
| Adams, BW; Moghaddam, B | 1 |
| Carlsson, A; Carlsson, ML; Nilsson, M; Waters, N; Waters, S | 1 |
| Dai, J; Ichikawa, J; Meltzer, HY | 1 |
| Ichikawa, J; Liégeois, JF; Meltzer, HY | 1 |
| Alboszta, AR; Bonaccorso, S; Dai, J; Ichikawa, J; Li, Z; Meltzer, HY | 1 |
| Ashby, CR; Blackburn, TP; Hashimoto, K; Middlemiss, DN; Minabe, Y; Shirayama, Y | 1 |
| Abekawa, T; Honda, M; Ito, K; Koyama, T | 1 |
| Conway, MW; Heron-Maxwell, C; Monn, JA; O'Neill, MF; Ornstein, P | 1 |
| De Deurwaerdère, P; Navailles, S; Porras, G; Spampinato, U | 1 |
| Baker, LE; Meltzer, HY; Prus, AJ | 1 |
| Arvanitis, L; Bauer, D; Meltzer, HY; Rein, W | 1 |
| Marona-Lewicka, D; Nichols, DE; Thisted, RA | 1 |
| Blessing, WW | 1 |
| Barth, VN; Chernet, E; Li, D; Martin, LJ; Need, AB; Phebus, LA; Rash, KS | 1 |
| Dai, J; Huang, M; Ichikawa, J; Li, Z; Meltzer, HY; Prus, AJ | 1 |
| Benaliouad, F; Kapur, S; Rompré, PP | 1 |
| Hertel, P | 1 |
| Chu, K; Jung, KH; Lee, SK; Nam, H; Park, KI; Sinn, DI | 1 |
| Gajendiran, M | 1 |
| Kessler, RM | 1 |
| Arnt, J; Mørk, A; Witten, LM | 1 |
| Cathala, A; Drago, F; Leggio, GM; Neny, M; Piazza, PV; Rouge-Pont, F; Spampinato, U | 1 |
| Li, M; Zhao, C | 1 |
| Imaki, J; Ohno, Y; Okano, M; Okumura, T; Shimizu, S; Tatara, A | 1 |
| Hu, G; Li, M; Sun, T; Zhang, C | 1 |
| Creed-Carson, M; Nobrega, JN; Oraha, A | 1 |
| Farrell, MS; Kroeze, WK; Roth, BL; Yadav, PN | 1 |
| Adamik, A; Jászberényi, M; Telegdy, G | 1 |
| Gen, K; Inoue, Y; Suzuki, H | 1 |
| Fijał, K; Nikiforuk, A; Popik, P | 1 |
| Adamik, A; Telegdy, G | 1 |
| Caraci, F; Cathala, A; Devroye, C; Di Marco, B; Drago, F; Piazza, PV; Spampinato, U | 1 |
| Alemany-González, M; Chanovas, J; Delgado-Sallent, C; Gener, T; Nebot, P; Puig, MV; Tauste Campo, A | 1 |
| Makiguchi, A; Okada, T; Shioda, K; Suda, S | 1 |
1 trial(s) available for haloperidol and mdl 100907
| Article | Year |
|---|---|
Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cannabinoids; Double-Blind Method; Drugs, Investigational; Female; Haloperidol; Humans; Male; Middle Aged; Neurotensin; Peptide Fragments; Piperidines; Placebos; Psychotic Disorders; Pyrazoles; Pyrrolidonecarboxylic Acid; Receptors, Neurokinin-3; Research Design; Rimonabant; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists; Treatment Outcome | 2004 |
48 other study(ies) available for haloperidol and mdl 100907
| Article | Year |
|---|---|
Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers.
Topics: Binding Sites; Ether-A-Go-Go Potassium Channels; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Potassium Channel Blockers; Protein Binding; Protein Conformation | 2009 |
5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Animals; Brain Chemistry; Dialysis; Dopamine; Fluorobenzenes; Haloperidol; Homovanillic Acid; Male; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Rats; Rats, Sprague-Dawley; Reserpine; Serotonin Antagonists | 1992 |
5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats.
Topics: Amphetamines; Animals; Antipsychotic Agents; Dose-Response Relationship, Drug; Fenfluramine; Fluorobenzenes; Haloperidol; Male; Piperidines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Reflex, Startle; Serotonin Receptor Agonists | 1996 |
Comparison of neurotensin responses to MDL 100,907, a selective 5HT2A antagonist, with clozapine and haloperidol.
Topics: Animals; Caudate Nucleus; Clozapine; Fluorobenzenes; Globus Pallidus; Haloperidol; Male; Neurotensin; Piperidines; Rats; Rats, Sprague-Dawley; Serotonin Antagonists | 1997 |
Disruption of latent inhibition in the rat by the 5-HT2 agonist DOI: effects of MDL 100,907, clozapine, risperidone and haloperidol.
Topics: Amphetamines; Animals; Antipsychotic Agents; Clozapine; Conditioning, Operant; Fluorobenzenes; Haloperidol; Male; Piperidines; Rats; Rats, Sprague-Dawley; Reflex, Startle; Reinforcement, Psychology; Risperidone; Serotonin Antagonists; Serotonin Receptor Agonists | 1997 |
M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro.
Topics: Animals; Antipsychotic Agents; Clozapine; Fluorobenzenes; Haloperidol; Male; Patch-Clamp Techniques; Piperidines; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Serotonin Antagonists | 1998 |
A novel computer-controlled conditioned avoidance apparatus for rats.
Topics: Amphetamines; Animals; Antipsychotic Agents; Avoidance Learning; Benzazepines; Clozapine; Computers; Cross-Over Studies; Dopamine Antagonists; Fluorobenzenes; Haloperidol; Male; Physical Conditioning, Animal; Piperidines; Raclopride; Rats; Rats, Sprague-Dawley; Salicylamides; Serotonin Antagonists; Serotonin Receptor Agonists | 1997 |
M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice.
Topics: Animals; Antipsychotic Agents; Clozapine; Excitatory Amino Acid Antagonists; Fluorobenzenes; Haloperidol; In Vitro Techniques; Male; Patch-Clamp Techniques; Phencyclidine; Piperidines; Prefrontal Cortex; Pyramidal Cells; Raclopride; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Salicylamides; Serotonin Antagonists | 1998 |
Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Fluorobenzenes; Haloperidol; Male; Nucleus Accumbens; Olanzapine; Piperidines; Pirenzepine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Time Factors | 1998 |
Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist.
Topics: Animals; Binding, Competitive; Catalepsy; Cell Line; Dopamine Antagonists; Fluorobenzenes; Haloperidol; Humans; Indoles; Male; Piperidines; Quinolines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Antagonists | 1999 |
The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice.
Topics: Amphetamine; Animals; Dizocilpine Maleate; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluorobenzenes; Glutamic Acid; Haloperidol; Hyperkinesis; Male; Mice; Mice, Inbred Strains; Motor Activity; N-Methylaspartate; Piperazines; Piperidines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists | 1999 |
Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo.
Topics: 3T3 Cells; Animals; Antipsychotic Agents; Benzodiazepines; Cell Line; Clozapine; Dendrites; Fluorobenzenes; Haloperidol; Mianserin; Mice; Olanzapine; Piperidines; Pirenzepine; Prefrontal Cortex; Pyramidal Cells; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Recombinant Proteins; Risperidone; Ritanserin; Serotonin Antagonists; Transfection | 1999 |
The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Clozapine; Corpus Striatum; Dopamine; Fluorobenzenes; Haloperidol; Male; Microdialysis; Nucleus Accumbens; Piperazines; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Risperidone; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tritium | 2000 |
Acute and repeated administration of the selective 5-HT(2A) receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study.
Topics: Action Potentials; Animals; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluorobenzenes; Haloperidol; Injections, Intravenous; Male; Neurons; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists; Substantia Nigra; Ventral Tegmental Area | 2001 |
Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.
Topics: Animals; Avoidance Learning; Catalepsy; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Extrapyramidal Tracts; Fluorobenzenes; Haloperidol; Male; Piperidines; Raclopride; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Antagonists | 2001 |
Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex.
Topics: Animals; Clozapine; Fluorobenzenes; Glutamic Acid; Haloperidol; Male; Microdialysis; Phencyclidine; Piperidines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Serotonin Antagonists | 2001 |
A behavioural pattern analysis of hypoglutamatergic mice--effects of four different antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Dizocilpine Maleate; Dopamine Antagonists; Drug Combinations; Excitatory Amino Acid Antagonists; Fluorobenzenes; Glutamic Acid; Haloperidol; Injections, Intraperitoneal; Male; Mice; Motor Activity; Piperidines; Risperidone; Serotonin Antagonists | 2001 |
5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acetylcholine; Animals; Clozapine; Corpus Striatum; Dopamine Antagonists; Fluorobenzenes; Haloperidol; Indophenol; Male; Microdialysis; Nucleus Accumbens; Piperazines; Piperidines; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 2002 |
5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner.
Topics: Animals; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Extracellular Space; Fluorobenzenes; Haloperidol; Male; Microdialysis; Nucleus Accumbens; Piperidines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Antagonists | 2002 |
SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Topics: Analysis of Variance; Animals; Dopamine; Dopamine Antagonists; Drug Synergism; Fluorobenzenes; Haloperidol; Male; Nucleus Accumbens; Phenols; Piperidines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Antagonists; Telencephalon | 2002 |
Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Action Potentials; Analysis of Variance; Animals; Apomorphine; beta-Cyclodextrins; Cell Count; Clozapine; Cyclodextrins; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Haloperidol; Indoles; Male; Neurons; Pyridines; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Substantia Nigra; Ventral Tegmental Area | 2002 |
Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and alpha1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Chromatography, High Pressure Liquid; Clozapine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; Haloperidol; Male; Microdialysis; Motor Activity; Phencyclidine; Piperidines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D4; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Stereotyped Behavior; Thiazoles; Time Factors | 2003 |
Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice.
Topics: Amino Acids; Animals; Benzazepines; Dizocilpine Maleate; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Fluorobenzenes; Haloperidol; Hyperkinesis; Mice; Motor Activity; Piperidines; Receptors, Metabotropic Glutamate; Serotonin Antagonists; Time Factors; Xanthenes | 2003 |
In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.
Topics: Aminopyridines; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Cocaine; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Interactions; Electrochemistry; Ethylamines; Extracellular Space; Haloperidol; Indoles; Male; Microdialysis; Nucleus Accumbens; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Time Factors | 2004 |
Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Butyrophenones; Clozapine; Discrimination, Psychological; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Fluorobenzenes; Generalization, Stimulus; Haloperidol; Male; Muscarinic Antagonists; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Trihexyphenidyl | 2004 |
Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
Topics: Amphetamine; Amphetamines; Animals; Apomorphine; Behavior, Animal; Cues; Discrimination Learning; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluorobenzenes; Hallucinogens; Haloperidol; Indans; Injections, Intraperitoneal; Lysergic Acid Diethylamide; Male; Piperidines; Psychotic Disorders; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 2005 |
Clozapine increases cutaneous blood flow and reduces sympathetic cutaneous vasomotor alerting responses (SCVARs) in rats: comparison with effects of haloperidol.
Topics: Animals; Antipsychotic Agents; Arousal; Clozapine; Dose-Response Relationship, Drug; Haloperidol; Injections, Subcutaneous; Laser-Doppler Flowmetry; Lipopolysaccharides; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Skin; Skin Temperature; Sympathetic Nervous System; Vasoconstriction; Vasomotor System | 2005 |
Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: dopamine D2, serotonin 2A and NK-1 receptors as examples.
Topics: Animals; Antipsychotic Agents; Aprepitant; Benzodiazepines; Brain; Chromatography, High Pressure Liquid; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Evaluation, Preclinical; Fluorobenzenes; Gerbillinae; Haloperidol; Male; Mass Spectrometry; Morpholines; Neurokinin-1 Receptor Antagonists; Olanzapine; Piperidines; Raclopride; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Neurokinin-1; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Tetrazoles | 2005 |
ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Topics: Aminopyridines; Animals; Chromatography, High Pressure Liquid; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Indoles; Male; Microdialysis; Norepinephrine; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2005 |
Blockade of 5-HT2a receptors reduces haloperidol-induced attenuation of reward.
Topics: Analysis of Variance; Animals; Behavior, Animal; Body Temperature Regulation; Clozapine; Differential Threshold; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Electric Stimulation; Extinction, Psychological; Fluorobenzenes; Haloperidol; Male; Piperidines; Rats; Rats, Sprague-Dawley; Reward; Self Administration; Serotonin 5-HT2 Receptor Antagonists | 2007 |
Comparing sertindole to other new generation antipsychotics on preferential dopamine output in limbic versus striatal projection regions: mechanism of action.
Topics: Animals; Antipsychotic Agents; Clozapine; Corpus Striatum; Dopamine; Dopamine Agents; Efferent Pathways; Haloperidol; Imidazoles; Indoles; Limbic System; Male; Presynaptic Terminals; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Agents; Synaptic Transmission | 2006 |
Status epilepticus associated with sertindole.
Topics: Anticonvulsants; Antipsychotic Agents; Brain; Brain Chemistry; Dose-Response Relationship, Drug; Electroencephalography; Female; Haloperidol; Humans; Imidazoles; Indoles; Middle Aged; Phenytoin; Receptor, Serotonin, 5-HT2C; Schizophrenia; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Status Epilepticus; Treatment Outcome | 2007 |
Differential effects of spinal 5-HT1A receptor activation and 5-HT2A/2C receptor desensitization by chronic haloperidol.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Antipsychotic Agents; Dyskinesia, Drug-Induced; Electrophysiology; Haloperidol; Male; Rats; Rats, Wistar; Receptors, Dopamine D2; Reflex, Monosynaptic; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Receptor Agonists; Spinal Cord | 2007 |
Aripiprazole: what is the role of dopamine D(2) receptor partial agonism?
Topics: Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Haloperidol; Humans; Hyperprolactinemia; Piperazines; Quinolones; Receptors, Dopamine D2; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists; Synaptic Transmission | 2007 |
Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: a comparison with risperidone and exploration of mechanisms involved.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Dopamine; Dopamine D2 Receptor Antagonists; Drug Synergism; Extracellular Space; Fluorobenzenes; Glutamic Acid; Haloperidol; Imidazoles; Indoles; Male; Microdialysis; Piperidines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Risperidone; Serotonin 5-HT2 Receptor Antagonists | 2009 |
In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
Topics: Aminopyridines; Analgesics, Opioid; Animals; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Ethylamines; Extracellular Space; Haloperidol; Indoles; Male; Microdialysis; Microinjections; Morphinans; Neural Pathways; Nucleus Accumbens; Piperazines; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2009 |
c-Fos identification of neuroanatomical sites associated with haloperidol and clozapine disruption of maternal behavior in the rat.
Topics: Amphetamines; Animals; Animals, Newborn; Antipsychotic Agents; Biomarkers; Brain; Clozapine; Dopamine; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Female; Haloperidol; Immunohistochemistry; Male; Maternal Behavior; Neostriatum; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Quinpirole; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Septum of Brain; Serotonin 5-HT2 Receptor Antagonists; Serotonin Receptor Agonists | 2010 |
Atypical antipsychotic properties of blonanserin, a novel dopamine D2 and 5-HT2A antagonist.
Topics: Animals; Antipsychotic Agents; Catalepsy; Corpus Striatum; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Haloperidol; Male; Mice; Mice, Inbred Strains; Nucleus Accumbens; Piperazines; Piperidines; Proto-Oncogene Proteins c-fos; Pyridines; Serotonin 5-HT2 Receptor Antagonists | 2010 |
Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Administration Schedule; Haloperidol; Male; Olanzapine; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2010 |
Effects of 5-HT(2A) and 5-HT(2C) receptor antagonists on acute and chronic dyskinetic effects induced by haloperidol in rats.
Topics: Aminopyridines; Animals; Antipsychotic Agents; Brain Chemistry; Catalepsy; Dyskinesia, Drug-Induced; Fluorobenzenes; Gene Expression Regulation; Haloperidol; Immunohistochemistry; In Situ Hybridization; Indoles; Ketanserin; Male; Mouth; Piperidines; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; RNA, Messenger; Serotonin Antagonists | 2011 |
Antagonist functional selectivity: 5-HT2A serotonin receptor antagonists differentially regulate 5-HT2A receptor protein level in vivo.
Topics: Animals; Behavior, Animal; Benzodiazepines; Blotting, Western; Clozapine; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Motor Activity; Olanzapine; Phencyclidine; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Serotonin Receptor Agonists; Stereotyped Behavior; Up-Regulation | 2011 |
Involvement of neurotransmitters in the action of apelin-13 on passive avoidance learning in mice.
Topics: Adipokines; Animals; Apelin; Atropine; Avoidance Learning; Bicuculline; Cyproheptadine; Dopamine Antagonists; GABA-A Receptor Antagonists; Haloperidol; Intercellular Signaling Peptides and Proteins; Male; Mice; Muscarinic Antagonists; Neurotransmitter Agents; Nitric Oxide Synthase; Nitroarginine; Serotonin 5-HT2 Receptor Antagonists | 2013 |
Comparison of the anti-dopamine D₂ and anti-serotonin 5-HT(2A) activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof.
Topics: Adult; Algorithms; Antipsychotic Agents; Biotransformation; Brain; Chlorpromazine; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Haloperidol; Humans; Male; Middle Aged; Neurons; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists; Young Adult | 2013 |
Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats.
Topics: Animals; Antipsychotic Agents; Clozapine; Data Interpretation, Statistical; Dizocilpine Maleate; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Fluorobenzenes; Haloperidol; Male; Piperazines; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Reflex, Startle; Risperidone; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sulfonamides; Thiophenes | 2014 |
Neurotransmitter-mediated anxiogenic action of PACAP-38 in rats.
Topics: Adrenergic Antagonists; Adrenergic beta-Antagonists; Animals; Anxiety; Arginine; Atropine; Bicuculline; Dopamine Antagonists; Exploratory Behavior; Haloperidol; Male; Maze Learning; Methysergide; Muscarinic Antagonists; Naloxone; Narcotic Antagonists; Neurotransmitter Agents; Nitroso Compounds; Peptide Fragments; Phenoxybenzamine; Pituitary Adenylate Cyclase-Activating Polypeptide; Propranolol; Rats; Rats, Wistar; Receptors, GABA; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide; Serotonin 5-HT2 Receptor Antagonists | 2015 |
Central serotonin(2B) receptor blockade inhibits cocaine-induced hyperlocomotion independently of changes of subcortical dopamine outflow.
Topics: Animals; Cocaine; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Haloperidol; Male; Motor Activity; Pyrimidines; Quinpirole; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Antagonists | 2015 |
Serotonin 5-HT
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Antipsychotic Agents; Brain Waves; Cortical Synchronization; Dopamine Agonists; Dopamine Antagonists; Electroencephalography; Fluorobenzenes; Gamma Rhythm; Haloperidol; Hippocampus; Locomotion; Mice; Neural Pathways; Piperazines; Piperidines; Prefrontal Cortex; Pyridines; Quinpirole; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Risperidone; Serotonin Antagonists; Serotonin Receptor Agonists | 2019 |
Risperidone and 5-HT2A Receptor Antagonists Attenuate and Reverse Cocaine-Induced Hyperthermia in Rats.
Topics: Animals; Benzazepines; Cocaine; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Haloperidol; Hyperthermia; Ketanserin; Male; Rats; Rats, Wistar; Risperidone; Ritanserin; Serotonin 5-HT2 Receptor Antagonists | 2020 |